In Vivo Toxicology Market

Market Leader - In Vivo Toxicology Market

The in vivo toxicology market is projected to reach USD 6.14 Billion by 2022 from USD 4.40 Billion in 2017, at a CAGR of 6.9%. Factors such as increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests are driving the growth of this market.

In this report, the market is segmented by product, testing type, toxicity endpoint, testing facility, and region.

On the basis of product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models (including mice model, rat model, and other animal models). The instruments segment is expected to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing research focus on neurological disorders where physiological equipment is used and the increasing research capabilities focused on biological samples such as blood and urine. In the animal models subsegment, mice models segment is expected to grow at the highest CAGR during the forecast period owing to its similarities with human genomes, advantages over other animal models, and innovation in the transgenic models.

Based on testing type, the in vivo toxicology market is segmented into chronic, sub-chronic, sub-acute, and acute toxicology testing. The sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing neurological and anti-viral drug research, which require toxicity studies of more than two weeks.

Based on toxicity endpoint, the in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART), and other toxicity endpoints. The immunotoxicity segment is expected to register the highest CAGR during the forecast period. The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment.

On the basis of testing facility, the global in vivo toxicology market is segmented into outsourced testing facilities and in-house testing facilities. The outsourced testing facilities segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is mainly attributed to the increasing R&D investments and cost-saving strategies of pharmaceutical, biopharmaceutical, and medical devices companies, which in turn results in increasing outsourcing of services to CROs.

Geographically, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising number of CROs that offer cost-effective in vivo toxicology services, growing pharmaceuticals industry, and government initiatives for the development of research in the country are driving the growth of the in vivo toxicology market in China.  

Related Reports:

In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
BT 6000
Published ON
Feb, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In Vivo Toxicology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved